Blockchain-based health data exchange firm Avaneer Health secures $50M in seed funding

Avaneer Health, an interoperable healthcare data exchange company built on blockchain technology, has secured $50 million in seed funding from a number of large healthcare players.

Those backing the Chicago-based network include Aetna, Anthem, the Cleveland Clinic, Health Care Services Corporation, Sentara Healthcare, and the PNC Financial Services Group. The new money will be put into hiring additional team members and technology upgrades required to launch nationwide, the company said Jan. 13.

"Addressing administrative costs and creating a positive consumer experience requires connectivity and the type of data fluidity we have come to expect in other industries," Stuart Hanson, founding CEO of Avaneer Health, said in a statement. "We are very excited to jumpstart our network to enable healthcare organizations to work together with a foundation of trust to solve the 'last mile' problem in healthcare.”

The aforementioned companies, along with IBM, founded the startup in June 2021 and represent 80 million covered patients and 14 million visits per year.

Avaneer's member-based network initiates and streamlines care, helping payers exchange data, assess treatment eligibility, perform prior authorizations and other services.

"To achieve truly frictionless and seamless care, healthcare needs greater transparency and ease of navigation for all parties involved, particularly as we move toward greater adoption of value-based care,” said Tim Skeen, co-chair of Avaneer Health's Board of Directors and senior vice president and CIO of Sentara Healthcare.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.